Natural History of Netherton Syndrome
N/A
Terminated
NCT05902663
| Condition | Netherton Syndrome |
|---|
| Phase | N/A |
|---|
| Sponsor | Boehringer Ingelheim |
|---|
| Status | Terminated |
|---|
| Enrollment | 4 participants |
|---|
| Start date | Oct 9, 2024 |
|---|
| Completion date | Mar 31, 2025 |
|---|
| Results posted | Jun 24, 2026 |
|---|
Summary
The goal of this non-interventional study (NIS) is to collect real-world data to describe the natural history of Netherton Syndrome (NS).
Clinical Assessment of Severity of Netherton Syndrome (NS) by Ichthyosis Area Severity Index (IASI) at Enrolment, Within 2 Weeks of Enrolment and at 16 and 52 Weeks of Follow-up
At enrolment, 2 weeks after enrolment and at 16 and 52 weeks of follow-up or death, whichever comes first.
Open in BENITIONS
View on ClinicalTrials.gov
All trials
This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.